Log In
Print this Print this

PCM EGFR Mutation Detection Test, Trovera EGFR

  Manage Alerts
Collapse Summary General Information
Company Trovagene Inc.
DescriptionNon-invasive molecular diagnostic to detect EGFR exon 19 deletions, exon 20 T790M and exon 21 L858R mutations in urinary cell-free DNA (cfDNA)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics: Biomarkers and companion diagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect EGFR mutations in cancer patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today